The national state health service Britain will be the first in the world to offer an injection to treat cancer to hundreds of patients in England. A new type of treatment that could reduce times by up to three quarters.
After the approval of the Medicines and Healthcare Products Regulatory Agency (MHRA)England’s NHS said hundreds of patients treated with the immunotherapy, atezolizumab, they would receive a “subcutaneous” injection instead of a venous drip, leaving more time for other cancer patients. .
“This approval will not only allow us to offer convenient and faster care to our patients, but it will also allow our teams to treat more patients throughout the day,” said the Dr. Alexander Martinconsultant oncologist at West Suffolk NHS Foundation Trust.
NHS England said that atezolizumab, also known as Tecentriq, It is usually given to patients intravenously, directly into their veins via a drip, which can often take around 30 minutes or up to an hour for some patients when accessing a vein can be difficult.
“It takes about seven minutes, compared to 30 to 60 minutes for the current method of intravenous infusion,” he said. Marius ScholtzMedical Director of Roche Products Limited.